Center for Scientific Review; Notice of Closed Meetings, 61614-61615 [2012-24877]
Download as PDF
61614
Federal Register / Vol. 77, No. 196 / Wednesday, October 10, 2012 / Notices
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: October 3, 2012.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–24875 Filed 10–9–12; 8:45 am]
BILLING CODE 4140–01–P
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: October 2, 2012.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–24876 Filed 10–9–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Cancer Institute; Notice of
Closed Meeting
National Institutes of Health
rmajette on DSK2TPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2) notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections 552b(c)
(4) and 552b(c) (6), Title 5 U.S.C., as
amended. The purpose of this meeting
is to evaluate requests for development
resources for potential new cancer
diagnostics. The outcome of the
evaluation will be information for
consideration by an internal NCI
committee that will decide whether
NCI/DCTD should support the requests
and make available contract resources
for development of the potential
diagnostics to improve the treatment of
cancer. The research proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the
proposed research projects, the
disclosure of which would constitute a
clearly unwarranted invasion of
personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Clinical
Assay Development Program (CADP).
Date: November 27, 2012.
Time: 8 a.m.—3 p.m.
Agenda: To review grant applications for
the CADP.
Place: National Institutes of Health,
Neurosciences Building, 6001 Executive
Boulevard, Conference Room C, Rockville,
MD 20852.
Contact Person: Tracy G. Lively, Ph.D.,
Executive Secretary, Cancer Diagnosis
Program (CADP), National Cancer Institute,
NIH, 6130 Executive Boulevard, Room
6035A, Bethesda, MD 20892, 301–496–8639,
livelyt@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
VerDate Mar<15>2010
15:15 Oct 09, 2012
Jkt 229001
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflicts: Gastrointestinal Physiology/
Pathophysiology-2.
Date: October 30, 2012.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Patricia Greenwel, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2178,
MSC 7818, Bethesda, MD 20892, 301–435–
1169, greenwep@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflicts: Liver Biology and
Pathophysiology.
Date: October 31, 2012.
Time: 12 p.m. to 1:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Patricia Greenwel, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2178,
MSC 7818, Bethesda, MD 20892, 301–435–
1169, greenwep@csr.nih.gov.
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflicts: Transplantation, Tolerance, and
Tumor Immunology.
Date: November 6, 2012.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Jian Wang, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4095D,
MSC 7812, Bethesda, MD 20892, (301) 435–
2778, wangjia@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Behavioral Neuroscience.
Date: November 8–9, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites Chevy Chase
Pavillion, 4300 Military Road NW.,
Washington, DC 20015.
Contact Person: Kristin Kramer, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5205,
MSC 7846, Bethesda, MD 20892, (301) 437–
0911, kramerkm@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Cell, Computational, and
Molecular Biology.
Date; November 8, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Maria DeBernardi, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6158,
MSC 7892, Bethesda, MD 20892, 301–435–
1355, debernardima@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Brain Disorders, Language,
Communication and Related Neurosciences.
Date: November 8–9, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance Long Beach Hotel, 111
East Ocean Blvd., Long Beach, CA 90802.
Contact Person: Vilen A. Movsesyan,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4040M,
MSC 7806, Bethesda, MD 20892, 301–402–
7278, movsesyanv@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Bioengineering, Computation and
Modeling—AREA Review.
Date: November 8–9, 2012.
Time: 8:30 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\10OCN1.SGM
10OCN1
rmajette on DSK2TPTVN1PROD with NOTICES
Federal Register / Vol. 77, No. 196 / Wednesday, October 10, 2012 / Notices
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Marie-Jose Belanger,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5181,
MSC, Bethesda, MD 20892,
belangerm@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Biological Chemistry, Biophysics,
and Drug Discovery.
Date: November 8, 2012.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Bethesda,
(Formerly Holiday Inn Select), 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Sergei Ruvinov, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4158,
MSC 7806, Bethesda, MD 20892, 301–435–
1180, ruvinser@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Biological Chemistry, Biophysics,
and Drug Discovery.
Date: November 8, 2012.
Time: 10 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Dennis Hlasta, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6185,
MSC, Bethesda, MD 20892, 301–435–1047,
dennis.hlasta@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–11–
100: Alzheimer’s Disease Pilot Clinical
Trials.
Date: November 8, 2012.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Mark Lindner, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3182,
MSC 7770, Bethesda, MD 20892, 301–435–
0913, mark.lindner@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; AREA:
Endocrinology, Metabolism, Nutrition and
Reproduction.
Date: November 8, 2012.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Dianne Hardy, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6175,
Bethesda, MD 20892, 301–435–1154,
dianne.hardy@nih.gov.
VerDate Mar<15>2010
15:15 Oct 09, 2012
Jkt 229001
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Neural Injury and
Neurodegeneration.
Date: November 8, 2012.
Time: 1:30 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Seetha Bhagavan, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5194,
MSC 7846, Bethesda, MD 20892, (301) 237–
9838, bhagavas@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Language and Communication.
Date: November 8, 2012.
Time: 12 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Serena Chu, Ph.D.,
Scientific Review Officer, BBBP IRG, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3178,
MSC 7848, Bethesda, MD 20892, 301–500–
5829, sechu@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 3, 2012.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–24877 Filed 10–9–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer on (240) 276–1243.
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
61615
Project: Uniform Application for the
Mental Health Block Grant and
Substance Abuse Block Grant FY 2014–
2015 Application Guidance and
Instructions (OMB No. 0930–0168)—
Revision
The Substance Abuse and Mental
Health Services Administration
(SAMHSA) is requesting approval from
the Office of Management and Budget
(OMB) for a revision of the 2014 and
2015 Community Mental Health
Services Block Grant (MHBG) and
Substance Abuse Prevention and
Treatment Block Grant (SABG)
Guidance and Instructions into a
uniform block grant application.
Currently, the SABG and the MHBG
differ on a number of their practices
(e.g., data collection at individual or
aggregate levels) and statutory
authorities (e.g., method of calculating
MOE, stakeholder input requirements
for planning, set asides for specific
populations or programs, etc.).
Historically, the Centers within
SAMHSA that administer these block
grants have had different approaches to
application requirements and reporting.
To compound this variation, states have
had different structures for accepting,
planning, and accounting for the block
grants and the prevention set aside
within the SABG. As a result, how these
dollars are spent and what is known
about the services and clients that
receive these funds varies by block grant
and by state.
In addition, between 2014 and 2015,
32 million individuals who are
uninsured will have the opportunity to
enroll in Medicaid or private health
insurance. This expansion of health
insurance coverage will have a
significant impact on how State Mental
Health Authorities (SMHAs) and State
Substance Abuse Authorities (SSAs) use
their limited resources. Many
individuals served by these authorities
are funded through federal block grant
funds. SAMHSA proposes that block
grant funds be directed toward four
purposes: 1) to fund priority treatment
and support services for individuals
without insurance or who cycle in and
out of health insurance coverage; 2) to
fund those priority treatment and
support services not covered by
Medicaid, Medicare or private insurance
offered through the exchanges and that
demonstrate success in improving
outcomes and/or supporting recovery; 3)
to fund universal, selective and targeted
prevention activities and services; and
4) to collect performance and outcome
data to determine the ongoing
effectiveness of behavioral health
prevention, treatment and recovery
E:\FR\FM\10OCN1.SGM
10OCN1
Agencies
[Federal Register Volume 77, Number 196 (Wednesday, October 10, 2012)]
[Notices]
[Pages 61614-61615]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-24877]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflicts: Gastrointestinal Physiology/
Pathophysiology-2.
Date: October 30, 2012.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Patricia Greenwel, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2178, MSC 7818, Bethesda, MD
20892, 301-435-1169, greenwep@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflicts: Liver Biology and Pathophysiology.
Date: October 31, 2012.
Time: 12 p.m. to 1:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Patricia Greenwel, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2178, MSC 7818, Bethesda, MD
20892, 301-435-1169, greenwep@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflicts: Transplantation, Tolerance, and Tumor
Immunology.
Date: November 6, 2012.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Jian Wang, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4095D, MSC 7812, Bethesda, MD 20892, (301)
435-2778, wangjia@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowships: Behavioral Neuroscience.
Date: November 8-9, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites Chevy Chase Pavillion, 4300 Military Road
NW., Washington, DC 20015.
Contact Person: Kristin Kramer, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5205, MSC 7846, Bethesda, MD
20892, (301) 437-0911, kramerkm@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Cell, Computational, and Molecular Biology.
Date; November 8, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Maria DeBernardi, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6158, MSC 7892, Bethesda, MD
20892, 301-435-1355, debernardima@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowships: Brain Disorders, Language, Communication and
Related Neurosciences.
Date: November 8-9, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Renaissance Long Beach Hotel, 111 East Ocean Blvd., Long
Beach, CA 90802.
Contact Person: Vilen A. Movsesyan, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4040M, MSC 7806, Bethesda, MD
20892, 301-402-7278, movsesyanv@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Bioengineering, Computation and Modeling--AREA Review.
Date: November 8-9, 2012.
Time: 8:30 a.m. to 1 p.m.
Agenda: To review and evaluate grant applications.
[[Page 61615]]
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Marie-Jose Belanger, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5181, MSC, Bethesda, MD 20892,
belangerm@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Biological Chemistry, Biophysics, and Drug
Discovery.
Date: November 8, 2012.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Doubletree Hotel Bethesda, (Formerly Holiday Inn Select),
8120 Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Sergei Ruvinov, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4158, MSC 7806, Bethesda, MD
20892, 301-435-1180, ruvinser@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Biological Chemistry, Biophysics, and Drug
Discovery.
Date: November 8, 2012.
Time: 10 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892.
Contact Person: Dennis Hlasta, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6185, MSC, Bethesda, MD 20892, 301-435-1047,
dennis.hlasta@nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR-11-100: Alzheimer's Disease Pilot Clinical Trials.
Date: November 8, 2012.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Mark Lindner, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3182, MSC 7770, Bethesda, MD 20892, 301-435-
0913, mark.lindner@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; AREA: Endocrinology, Metabolism, Nutrition and Reproduction.
Date: November 8, 2012.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Dianne Hardy, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6175, Bethesda, MD 20892, 301-435-1154,
dianne.hardy@nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Neural Injury and Neurodegeneration.
Date: November 8, 2012.
Time: 1:30 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Seetha Bhagavan, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5194, MSC 7846, Bethesda, MD
20892, (301) 237-9838, bhagavas@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Language and Communication.
Date: November 8, 2012.
Time: 12 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Serena Chu, Ph.D., Scientific Review Officer,
BBBP IRG, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3178, MSC 7848, Bethesda, MD
20892, 301-500-5829, sechu@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: October 3, 2012.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-24877 Filed 10-9-12; 8:45 am]
BILLING CODE 4140-01-P